I. Introduction to CAS 96702-03-3

In the intricate world of chemical manufacturing and pharmaceutical development, precise identification is paramount. This is where the Chemical Abstracts Service (CAS) Registry Number system comes into play. A CAS Registry Number is a unique numerical identifier assigned to every chemical substance described in the open scientific literature, serving as an international standard for substance identification. It is a critical tool for chemists, researchers, regulators, and procurement specialists to eliminate ambiguity, as a single compound can have multiple synonyms. For instance, the compound with CAS:56-12-2 is universally recognized as gamma-aminobutyric acid (GABA), regardless of whether it is called 4-aminobutanoic acid or another trade name. This unambiguous identification ensures safety, facilitates global trade, and underpins regulatory compliance.

Within this framework, CAS 96702-03-3 holds a specific and vital position. It is identified as a key chemical intermediate in the synthesis of Tamsulosin Hydrochloride. Intermediates like this are the crucial building blocks or stepping-stone molecules in multi-step synthetic pathways. They are not the final active pharmaceutical ingredient (API) but are indispensable for its efficient and scalable production. The quality, purity, and availability of such intermediates directly impact the cost, yield, and overall viability of manufacturing the final drug.

Tamsulosin Hydrochloride itself is a well-established and widely prescribed pharmaceutical agent. It belongs to a class of drugs known as alpha-1 adrenergic receptor blockers. Its primary therapeutic use is in the treatment of benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland that commonly affects older men. By selectively relaxing the smooth muscle in the prostate and bladder neck, Tamsulosin Hydrochloride alleviates symptoms such as difficulty in starting urination, weak stream, and nocturia (frequent urination at night). Its efficacy and relatively favorable side-effect profile have made it a first-line therapy globally. The synthesis of this important drug relies on a carefully orchestrated sequence of chemical reactions, with CAS 96702-03-3 playing a pivotal role in one of the key steps, which we will explore in detail.

II. Chemical Properties and Structure of CAS 96702-03-3

Delving into the molecular specifics, CAS 96702-03-3 corresponds to a distinct organic compound with defined characteristics. Its systematic chemical name is typically (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide, or a closely related variant depending on the exact synthetic step it represents. The molecular formula is C₂₀H₂₈N₂O₅S. This formula reveals a molecule of considerable complexity, incorporating carbon, hydrogen, nitrogen, oxygen, and sulfur atoms.

Key physical and chemical properties are essential for its handling and use in synthesis:

• Molecular Weight: Approximately 408.51 g/mol.
• Appearance: It is commonly described as a white to off-white crystalline powder.
• Solubility: The compound's solubility profile is crucial for reaction planning. It is generally soluble in organic solvents like dimethylformamide (DMF), dimethyl sulfoxide (DMSO), and dichloromethane, but has limited solubility in water.
• Melting Point: It possesses a specific melting point range, which serves as a critical purity indicator during quality control. Typical values range from 145°C to 150°C.
• Optical Activity: As suggested by the (R)- designation in its name, this intermediate is chiral. The specific three-dimensional arrangement of atoms around a stereocenter is vital for its biological activity and its correct conversion into the final active enantiomer of Tamsulosin.

Structurally, CAS 96702-03-3 is characterized by several key functional groups that define its reactivity and role. The molecule features a benzenesulfonamide moiety (an aromatic ring attached to a sulfonamide group, -SO₂NH₂), which is a common pharmacophore in many drugs and contributes to specific binding interactions. It contains ether linkages (-O-) connecting aromatic rings, which influence the molecule's conformation and solubility. An amine group (-NH-) is present within an ethylamino chain, which is often a site for further chemical modification or salt formation. Finally, the presence of methoxy (-OCH₃) and ethoxy (-OCH₂CH₃) groups adds to the lipophilic character of the molecule. This specific assembly of functional groups makes it a tailored precursor perfectly suited for the final cyclization or coupling step to form the Tamsulosin core structure.

III. Synthesis and Manufacturing Processes

The industrial synthesis of CAS 96702-03-3 is a testament to modern organic chemistry and process optimization. It is typically not the starting point but rather an advanced intermediate synthesized over several steps from more basic raw materials. One common synthetic route involves the sequential construction of the molecule's two aromatic ether systems and the chiral side chain, culminating in the formation of the sulfonamide group or its direct introduction via a sulfonation/amination sequence.

The manufacturing process relies on specific raw materials and controlled conditions. Key starting materials often include derivatives of guaiacol (2-methoxyphenol) and phenetole (ethoxyphenol) to build the ether-linked aromatic portions. The introduction of chirality is a critical aspect, often achieved early in the synthesis using a chiral pool starting material like (R)-1-chloro-2-propanol or via asymmetric synthesis techniques. The sulfonamide group may be introduced using reagents like chlorosulfonic acid followed by ammonolysis. Reaction conditions are meticulously controlled:

• Temperature: Reactions are carried out in specific ranges, often between -10°C for sensitive steps like sulfonation to 80-120°C for condensation or amination reactions.
• Solvents: Polar aprotic solvents like DMF, acetonitrile, or toluene are commonly used.
• Catalysts: Bases such as potassium carbonate or triethylamine are used to facilitate ether formations and deprotonations.
• Atmosphere: Some steps may require an inert atmosphere (nitrogen or argon) to prevent oxidation of sensitive intermediates.

Quality control (QC) in the manufacturing of pharmaceutical intermediates is non-negotiable. For CAS 96702-03-3, stringent measures are implemented to ensure it meets the specifications required for the subsequent API synthesis. This involves a battery of analytical tests:

Test Parameter	Method	Specification Purpose
Identity (IR, NMR)	Spectroscopy	Confirms the correct molecular structure.
Assay (HPLC)	Chromatography	Determines the percentage purity of the main component.
Chiral Purity (Chiral HPLC)	Chromatography	Ensures the correct enantiomer is present (>99% is typical).
Related Substances (HPLC)	Chromatography	Identifies and quantifies impurities and by-products.
Residual Solvents (GC)	Chromatography	Ensures toxic solvents from manufacturing are below ICH limits.
Loss on Drying (LOD)	Gravimetric	Measures volatile content (water, solvents).
Melting Point	Capillary Method	Provides a quick physical purity check.

Adherence to these QC protocols ensures that the intermediate will perform predictably in the final API synthesis, safeguarding the quality, safety, and efficacy of the final drug product. It's worth noting that other intermediates, such as those with CAS:9012-19-5 (a specific grade of polyvinylpyrrolidone, often used as a binder or stabilizer in drug formulations), undergo similarly rigorous but different QC testing tailored to their polymeric nature and functional role.

IV. Applications in Pharmaceutical Industry

The primary and most significant application of CAS 96702-03-3 is unequivocally its role as a penultimate or advanced intermediate in the commercial production of Tamsulosin Hydrochloride. In the synthetic pathway, this compound is typically subjected to a final step, such as a salt formation with hydrochloric acid or a cyclization reaction, to yield the active pharmaceutical ingredient in its final salt form. Its structural design incorporates all the necessary elements of the Tamsulosin molecule—the chiral center, the two aromatic ether groups, and the sulfonamide—in a configuration ready for the concluding transformation. The efficiency and yield of this final step are highly dependent on the purity and chiral integrity of CAS 96702-03-3. Therefore, its reliable supply chain is critical for global Tamsulosin API manufacturers.

Beyond its flagship application, the structural motif of CAS 96702-03-3 suggests potential utility in other areas of drug synthesis. Its core contains a biaryl ether linkage and a sulfonamide group, both of which are privileged scaffolds in medicinal chemistry. Researchers investigating new alpha-adrenergic receptor modulators, or drugs targeting other G-protein-coupled receptors, might utilize similar structures as starting points for molecular diversification. Furthermore, the synthetic methodologies developed for its efficient and enantioselective production can serve as a valuable reference for the synthesis of other complex amines and sulfonamide-containing therapeutics.

Regulatory considerations are paramount when dealing with any pharmaceutical intermediate. Manufacturers of CAS 96702-03-3 must operate in compliance with Good Manufacturing Practice (GMP) guidelines. This encompasses every aspect from the qualification of starting materials (ensuring they are from approved sources with proper documentation, similar to the standards expected for a raw material like CAS:56-12-2 when used in a GMP context) to the validation of manufacturing processes, rigorous QC testing, and comprehensive documentation. Regulatory agencies, such as the Hong Kong Department of Health's Drug Office, which oversees pharmaceutical registration and compliance, expect a full trail of documentation (the "Data Integrity" principle) for any intermediate that impacts the quality of the final drug. A 2022 review by Hong Kong's regulatory authority emphasized the growing scrutiny on the control of genotoxic impurities in APIs and their intermediates, a concern that directly impacts the impurity profile analysis of compounds like CAS 96702-03-3. Compliance ensures that the intermediate is fit for its intended use in producing a safe and effective medicine.

V. Safety and Handling of CAS 96702-03-3

Like many synthetic organic intermediates, CAS 96702-03-3 requires careful handling based on its inherent hazardous properties. A thorough review of its Safety Data Sheet (SDS) is mandatory before any laboratory or industrial use. While the full toxicological profile may not be as extensively documented as for the final API, hazard assessments are based on its chemical structure, similar compounds, and available data.

Toxicity and Hazard Information:

• Acute Toxicity: It may be harmful if swallowed, inhaled, or absorbed through the skin. Specific LD50 data should be consulted from the supplier's SDS.
• Irritation: The compound is likely to cause irritation to the skin, eyes, and respiratory tract. Dust generated during handling can be a particular irritant.
• Sensitization: There is a potential for causing skin sensitization (allergic reaction) upon repeated or prolonged exposure.
• Environmental Hazard: Information may be limited, but as an organic compound, it should not be released into the environment and requires proper disposal.

Safe Handling and Storage Procedures:

• Personal Protective Equipment (PPE): Minimum PPE includes safety glasses or goggles, appropriate chemical-resistant gloves (e.g., nitrile), and a lab coat. Respiratory protection (dust mask or respirator) is necessary when handling powder in a way that generates airborne dust.
• Engineering Controls: Use in a well-ventilated area, preferably within a fume hood for weighing and transferring operations to control dust and vapor exposure.
• Hygiene Measures: Avoid contact with skin and eyes. Do not eat, drink, or smoke in areas where the chemical is handled. Wash hands thoroughly after handling.
• Storage: Store in a cool, dry, well-ventilated place. Keep the container tightly closed and clearly labeled. Store away from incompatible materials such as strong oxidizing agents. The storage area should comply with local regulations for industrial chemicals.

Emergency Measures and First Aid:

• Inhalation: Move person to fresh air. If breathing is difficult, give oxygen. Seek immediate medical attention.
• Skin Contact: Immediately remove contaminated clothing. Wash skin thoroughly with plenty of soap and water for at least 15 minutes. Seek medical advice if irritation persists.
• Eye Contact: Rinse cautiously with water for several minutes, holding eyelids open. Remove contact lenses if present and easy to do. Continue rinsing. Seek immediate medical attention.
• Ingestion: Rinse mouth. Do NOT induce vomiting unless directed by medical personnel. Give water to drink if the person is conscious. Seek immediate medical attention.
• Spill: For small spills, wear appropriate PPE, dampen with water to suppress dust, and collect material with a non-sparking tool. Place in a suitable, labeled container for disposal. For large spills, evacuate the area and contact professional emergency services.

Proper disposal must follow all applicable local, regional, and national regulations, such as those enforced by Hong Kong's Environmental Protection Department for chemical waste.

VI. Conclusion

The significance of CAS 96702-03-3 extends far beyond its alphanumeric identifier. It represents a critical nexus in the value chain of a vital therapeutic agent, Tamsulosin Hydrochloride. Its well-defined chemical structure, underpinned by stringent synthetic and quality control protocols, ensures the reliable and efficient production of a drug that improves the quality of life for millions of patients worldwide with benign prostatic hyperplasia. The compound exemplifies the importance of advanced intermediates in modern pharmaceutical manufacturing, where control over chirality, purity, and impurity profiles is non-negotiable for regulatory approval and patient safety.

Looking ahead, future trends and research opportunities related to CAS 96702-03-3 are likely to focus on continuous process improvement. This includes developing greener synthetic routes with higher atom economy, reduced solvent use, and more sustainable catalysts. Biocatalytic approaches using engineered enzymes to install the chiral center or form key bonds could offer more environmentally friendly alternatives. Furthermore, advancements in continuous flow chemistry may be applied to its synthesis, offering better control over exothermic reactions and improving overall safety and scalability. Research may also explore the derivatization of its core structure to discover new chemical entities with potential pharmacological activity beyond alpha-blockade. As the pharmaceutical industry evolves towards more personalized and targeted therapies, the lessons learned in the efficient and controlled synthesis of key intermediates like CAS 96702-03-3 will continue to inform the development of next-generation medicines.